About: Laurie E. Gaspar

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Laurie E. Gaspar Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	researcher (en) 연구원 (ko) wetenschapper (nl) дослідниця (uk)
rdfs:label	Laurie E. Gaspar (en) Laurie E. Gaspar (nl)
skos:prefLabel	Laurie E. Gaspar (en) Laurie E. Gaspar (nl)
name	Laurie E. Gaspar (en) Laurie E. Gaspar (nl)
given name	wds:Q100728309-55893E87-11FF-4136-812A-C3204E2961E0
given name	Laurie
instance of	wds:Q100728309-E2BEC138-7672-48F2-819E-166D5B89FA18
instance of	Homo sapiens
Google Knowledge Graph ID	wds:Q100728309-C68698AB-7D04-4045-8D34-1AF5CCFB6A80
Google Knowledge Graph ID	http://g.co/kg/g/11f0yqyb51
Google Knowledge Graph ID	/g/11f0yqyb51
ResearchGate profile ID	wds:Q100728309-C95E0FE9-7967-43DC-9DD3-D26B8923F429
ResearchGate profile ID	Laurie-Gaspar
occupation	wds:Q100728309-E0755606-32BE-4835-9567-C78B5DC1AA6F
WorldCat Entities ID	wds:Q100728309-13647CFE-1170-4DFC-A538-6890FC6D22D4
sex or gender	wds:Q100728309-03469864-4b06-a5af-f422-5dae6e3d732d
VIAF ID	wds:Q100728309-DBB882ED-BA83-4B94-A7F2-AC518E195027
Library of Congress authority ID	wds:Q100728309-b062c554-49f6-59bc-82b6-bad9f43fc14e
National Library of Israel J9U ID	wds:Q100728309-FA168E4C-9151-4C35-BB0A-54A073728918
VIAF ID	http://viaf.org/viaf/309830675
Library of Congress authority ID	http://id.loc.gov/authorities/names/n2014187282
occupation	researcher
WorldCat Entities ID	E39PCjrxyqt7k8WfY7wCMWQT9C
sex or gender	female organism
VIAF ID	309830675
Library of Congress authority ID	n2014187282
National Library of Israel J9U ID	987007379097905171
is owl:sameAs of	Laurie E. Gaspar
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q100728309 Laurie E. Gaspar
is author of	Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial RSR13 plus cranial radiation therapy in patients with brain metastases: comparison with the Radiation Therapy Oncology Group Recursive Partitioning Analysis Brain Metastases Database A phase I dose-escalation study of fractionated stereotactic radiosurgery in combination with gefitinib in patients with recurrent malignant gliomas. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guidelines for image-guided radiation therapy (IGRT) The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small-cell lung cancer Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer. Response assessment criteria for brain metastases: proposal from the RANO group. Update in the treatment of brain metastases from lung cancer The role of prophylactic anticonvulsants in the management of brain metastases: a systematic review and evidence-based clinical practice guideline The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) Practice Guidelines for Intensity-Modulated Radiation Therapy (IMRT) Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases Long-term survival with concurrent chemoradiation therapy followed by consolidation docetaxel in stage IIIB non-small-cell lung cancer: a phase II Southwest Oncology Group Study (S9504). Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases. Patterns of surgical care of lung cancer patients. A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer. Time from treatment to subsequent diagnosis of brain metastases in stage III non-small-cell lung cancer: a retrospective review by the Southwest Oncology Group Comparison of 4-dimensional computed tomography ventilation with nuclear medicine ventilation-perfusion imaging: a clinical validation study A Pilot Trial of Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Docetaxel and the Combination of Bevacizumab (NSC-704865) in Patients With Inoperable Locally Advanced Stage III Non-Small-Cell Lung Cancer: SWOG S0533 Small-cell lung cancer: prognostic factors and changing treatment over 15 years Hypofractionated-intensity modulated radiotherapy (hypo-IMRT) and temozolomide (TMZ) with or without bevacizumab (BEV) for newly diagnosed glioblastoma multiforme (GBM): a comparison of two prospective phase II trials. Stereotactic radiosurgery (SRS) for brain metastases: a systematic review Practice guideline for the performance of therapy with unsealed radiopharmaceutical sources Phase II trial of cisplatin/etoposide and concurrent radiotherapy followed by paclitaxel/carboplatin consolidation for limited small-cell lung cancer: Southwest Oncology Group 9713. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline The Impact of Postoperative Radiotherapy for Thymoma and Thymic Carcinoma Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus. Recursive partitioning analysis of pretreatment variables of 416 patients with locoregional esophageal cancer treated with definitive concomitant chemoradiotherapy on Intergroup and Radiation Therapy Oncology Group trials Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group. Consolidation Docetaxel After Concurrent Chemoradiotherapy in Stage IIIB Non–Small-Cell Lung Cancer: Phase II Southwest Oncology Group Study S9504 National survey of non-small cell lung cancer in the United States: epidemiology, pathology and patterns of care Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis Prophylactic cranial irradiation for patients with lung cancer The role of chemotherapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy ACR Appropriateness Criteria® follow-up and retreatment of brain metastases Cooperative group research efforts in lung cancer 2008: focus on advanced-stage non-small-cell lung cancer Retrospective clinicopathologic correlation of gross tumor size of hepatocellular carcinoma: implications for stereotactic body radiotherapy. Phase I dose escalation trial of vandetanib with fractionated radiosurgery in patients with recurrent malignant gliomas. Regional normal lung tissue density changes in patients treated with stereotactic body radiation therapy for lung tumors Southwest Oncology Group: two decades of experience in non-small cell lung cancer Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group. Brain Metastases from NSCLC: Radiation Therapy in the Era of Targeted Therapies Radiotherapeutic Management of Non-Small Cell Lung Cancer in the Minimal Resource Setting. Interim analysis of a prospective phase I/II trial of SBRT for liver metastases. Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214. Phase II trial of hypofractionated IMRT with temozolomide for patients with newly diagnosed glioblastoma multiforme. Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme. The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guideline Radiation Therapy for Oligometastatic Non-Small Cell Lung Cancer: Theory and Practice Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma Phase II study of consolidation paclitaxel after concurrent chemoradiation in poor-risk stage III non-small-cell lung cancer: SWOG S9712.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software